Cargando…
Pharmacogenetic-Based Interactions between Nutraceuticals and Angiogenesis Inhibitors
Background: Angiogenesis inhibitors (AIs) have become established as an effective cancer treatment. Whereas their interactions with antineoplastic drugs have extensively been investigated, little is known of the effect of their co-administration with nutraceuticals/dietary supplements (N/DSs), which...
Autores principales: | Di Francia, Raffaele, Berretta, Massimiliano, Benincasa, Giulio, D’Avino, Alfredo, Facchini, Sergio, Costagliola, Domenico, Rossi, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627675/ https://www.ncbi.nlm.nih.gov/pubmed/31151284 http://dx.doi.org/10.3390/cells8060522 |
Ejemplares similares
-
Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
por: Berretta, Massimiliano, et al.
Publicado: (2016) -
Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies
por: Berretta, Massimiliano, et al.
Publicado: (2018) -
Drug–Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection
por: Berretta, Massimiliano, et al.
Publicado: (2016) -
Taurisolo®, a Grape Pomace Polyphenol Nutraceutical Reducing the Levels of Serum Biomarkers Associated With Atherosclerosis
por: Annunziata, Giuseppe, et al.
Publicado: (2021) -
Glutathione: Lights and Shadows in Cancer Patients
por: Marini, Herbert Ryan, et al.
Publicado: (2023)